New IBD treatment shows promise in Real-World patient study
Disease control
Completed
This study followed 150 patients with inflammatory bowel disease (including Crohn's disease and ulcerative colitis) who received Vedolizumab treatment as part of their regular medical care. Researchers tracked how well the treatment worked and monitored for side effects over one …
Sponsor: AryoGen Pharmed Co. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC